4559:TYO
Zeria Pharmaceutical Co Ltd
JP¥2.019,00
arrow_upward
+0,55%(+11,00) 1 HR
20 Okt, 15.30.00 GMT+9 · JPY
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 4559...
Pembukaan
JP¥2.008
Tinggi
JP¥2.022
Rendah
JP¥2.004
Kapitalisasi pasar
101,19 M
Volume rata-rata
158,24 rb
Volume
89,50 rb
Dividen
2,43%
Dividen per kuartal
JP¥12
Tanggal tanpa dividen
29 Sep 2026
Rasio P/E
10,81
Harga tinggi dalam 52 minggu terakhir
JP¥2.434
Harga rendah dalam 52 minggu terakhir
JP¥1.878
EPS
JP¥187
Saham beredar
50,11 jt
Jumlah karyawan
2 rb
Pembukaan
JP¥2.008
Tinggi
JP¥2.022
Rendah
JP¥2.004
Kapitalisasi pasar
101,19 M
Volume rata-rata
158,24 rb
Volume
89,50 rb
Dividen
2,43%
Dividen per kuartal
JP¥12
Tanggal tanpa dividen
29 Sep 2026
Rasio P/E
10,81
Harga tinggi dalam 52 minggu terakhir
JP¥2.434
Harga rendah dalam 52 minggu terakhir
JP¥1.878
EPS
JP¥187
Saham beredar
50,11 jt
Jumlah karyawan
2 rb
Artikel berita
Dari sumber web dan partner berita
MarketBeat
·
25 menit yang lalu
Churchill Downs (NASDAQ:CHDN) Stock Gets Price Target Reduction from JPMorgan Chase & Co.
Yahoo Finance
·
1 jam yang lalu
Alnylam (ALNY): Can the RNAi Franchise Get it an Entry into the S&P 500 Index?
The Globe and Mail
·
24 menit yang lalu
Kaplan Fox Urges Duolingo, Inc. (NASDAQ: DUOL) Investors to Contact the Firm Before the Deadline on December 7, 2026
Insider Monkey
·
1 jam yang lalu
Okta (OKTA): Does the AI-Identity Turnaround Make It a Stronger S&P 500 Contestant?
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Tentang Zeria Pharmaceutical Co Ltd